Skip to main content

Day: September 27, 2021

Ferrellgas Names Dhiraj Cherian Chief Financial Officer

Written by Customer Service on . Posted in Public Companies.

Overland Park, KS, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC:FGPR), one of the nation’s largest propane logistics companies, announced today the hiring of Dhiraj Cherian as Chief Financial Officer. Cherian brings to Ferrellgas more than 20 years of financial management and strategic financial and operational goal achievement. He served most recently as Chief Financial Officer of Panasonic Automotive Systems Company, a tier one global connectivity and mobility technology leader in the automotive industry based in Atlanta. He joins Chairman and Chief Executive Officer Jim Ferrell and Chief Operating Officer Tamria Zertuche as executive officers of Ferrellgas. “Dhiraj Cherian possesses the attributes we need to continue to transform and grow our business,” Ferrell said. “He has demonstrated time and again...

Continue reading

New Topical Roflumilast Data Presented at the European Academy of Dermatology and Venereology (EADV) Congress

Written by Customer Service on . Posted in Public Companies.

WESTLAKE VILLAGE, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions, today announced that four abstracts for Arcutis’ topical roflumilast program in psoriasis, scalp and body psoriasis, and seborrheic dermatitis will be presented at European Academy of Dermatology and Venereology (EADV) Congress. Topical roflumilast is a selective and highly potent phosphodiesterase-4 inhibitor being investigated by Arcutis as a non-steroidal topical treatment for multiple inflammatory skin diseases. “Data continue to demonstrate that topical roflumilast delivers superior efficacy over vehicle across...

Continue reading

Xeriant to Join XTI Aircraft at the NBAA Convention and Other Company News

Written by Customer Service on . Posted in Public Companies.

Advanced Air Mobility to be Major Focus of the 2021 NBAA Convention BOCA RATON, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTCQB: XERI) (“Xeriant” or the “Company”), an aerospace company dedicated to Advanced Air Mobility, and its joint venture partner XTI Aircraft Company (“XTI”), an OEM and developer of the TriFan 600, a leading next-generation hybrid-electric VTOL aircraft, will be attending the upcoming National Business Aircraft Association (NBAA) Business Aircraft Convention and Exhibition (BACE) in Las Vegas, from October 12 to 14. XTI Aircraft will be exhibiting at the event alongside other Advanced Air Mobility (“AAM”) participants, including Bell, Honeywell, Jaunt Air Mobility, Kitty Hawk, Northern Plains UAS Test Site, and Overair. Federal perspectives on AAM will be shared in a panel discussion and moderated...

Continue reading

Salarius Pharmaceuticals to Present at the Virtual Benzinga Healthcare Small Cap Conference

Written by Customer Service on . Posted in Public Companies.

HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, announced today that David Arthur, Chief Executive Officer, will present virtually at the Benzinga Healthcare Small Cap Conference taking place September 29-30, 2021. The live virtual presentation can be accessed via the conference’s virtual platform by registered conference attendees. Details of the presentation are as follows: Event: Benzinga Healthcare Small Cap ConferenceDate: September 29, 2021Time: 10:50 a.m. ETRegistration: https://www.benzinga.com/events/small-cap/healthcare/During the presentation, Mr. Arthur will provide an overview of Salarius’ business...

Continue reading

PAE Successfully Defends Protest, Retains Position on $835M Air Force IDIQ and $84.3M Task Order Award

Written by Customer Service on . Posted in Public Companies.

FALLS CHURCH, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) — PAE (NASDAQ: PAE, PAEWW), a global leader merging technology with advanced business practices, delivering innovative solutions to the U.S. government and its host country partners, retained its position on the U.S. Air Force Rotary Wing Maintenance Contract Consolidation contract vehicle as the U.S. Government Accountability Office dismissed a bid protest raised by a competitor. The indefinite delivery, indefinite quantity contract vehicle has a ceiling value of $835 million and a 10-year period of performance. The resolution also permitted the Air Force to reinstate an initial five-year task order awarded to PAE on the contract, valued at $84.3 million, to support helicopter maintenance for training missions with the Air Education and Training Command at Kirtland Air Force Base...

Continue reading

Puyi Inc. Files Fiscal Year 2021 Annual Report on Form 20-F with the SEC and Hosts Conference Call

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

GUANGZHOU, China, Sept. 27, 2021 (GLOBE NEWSWIRE) — Puyi Inc. (“Puyi” or the “Company”) (NASDAQ: PUYI), a leading third-party wealth management service provider in China focusing on affluent and emerging middle class population, today announced that it has filed its annual report on Form 20-F, which contains its audited financial statements for the fiscal year ended June 30, 2021 (“2021 Annual Report”), with the U.S. Securities and Exchange Commission (the “SEC”) on September 27, 2021. The 2021 Annual Report can be accessed on the SEC’s website at http://www.sec.gov as well as on the Investor Relations page of the Company’s website at http://ir.puyiwm.com/financial-information/SEC-filings. Hard copies of the 2021 Annual Report are available and free of charge to its shareholders upon request. Senior management will host a combined...

Continue reading

POC Diagnostics Market Size is Projected to Reach USD 36.21 Billion by 2028

Written by Customer Service on . Posted in Mergers And Acquisitions.

Top Players Covered in the POC Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l’Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.S), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.S.), Bio-Rad Laboratories Inc. (California, U.S) and other key market players Pune, India, Sept. 27, 2021 (GLOBE NEWSWIRE) — The global POC Diagnostics Market size is projected to reach USD 36.21 billion by 2028, exhibiting a CAGR of -1.9% during the forecast period. The prevalence of several chronic disorders and the incorporation of nanotechnology...

Continue reading

Europe Canned Beverages Market to Hit USD 205.99 Billion by 2028; Increasing Consumer Preference towards Vegan Drinks to Augment Growth, Says Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Top companies covered in Europe canned beverages market are Anheuser-Busch InBev (Leuven, Belgium), Diageo Plc. (London, U.K.), Heineken NV (Amsterdam, Netherland), Pernod Ricard S.A. (Paris, France), Carlsberg Breweries A/S (Copenhagen, Denmark), Coca-Cola HBC AG (Zug, Switzerland), PepsiCo Inc. (New York, U.S.), Anadolu Efes Biracilik ve Malt Sanayii A.S. (Istanbul, Turkey), Red Bull GmbH (Fuschl, Austria), Nestle S.A. (Vevey, Switzerland), and more players profiled Pune, India, Sept. 27, 2021 (GLOBE NEWSWIRE) — The Europe canned beverages market size is expected to gain momentum by reaching USD 205.99 billion by 2028 from USD 156.38 billion in 2021 while exhibiting a CAGR of 4.0% between 2021 to 2028. In its report titled, “Europe Canned Beverages Market, 2021-2028.” Fortune Business Insights™ mentions that the market stood...

Continue reading

Intellia Therapeutics to Present at Chardan’s 5th Annual Genetic Medicines Conference

Written by Customer Service on . Posted in Public Companies.

CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at Chardan’s 5th Annual Genetic Medicines Conference on Monday, October 4, 2021 at 10:30 a.m. ET. A live webcast of Intellia’s presentation at this event will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcast, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Intellia’s website for approximately 14 days following the...

Continue reading

KemPharm to Present at the Benzinga Healthcare Small Cap Conference

Written by Customer Service on . Posted in Public Companies.

CELEBRATION, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that Travis C. Mickle, Ph.D., President and Chief Executive Officer of KemPharm, will present at the Benzinga Healthcare Small Cap Conference taking place September 29-30, 2001. The presentation will be available on the conference’s virtual platform to all registered attendees. Details of the presentation are as follows:Event: Benzinga Healthcare Small Cap ConferenceDate: September 30, 2021Time: 4:20 p.m., ETRegistration: https://www.benzinga.com/events/small-cap/healthcare/Following the conclusion of the event, a recording of Dr. Mickle’s presentation will be available under “Events & Presentations” in the Investor...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.